Literature DB >> 9667688

Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma.

S De Vita1, V Zagonel, A Russo, M Rupolo, R Cannizzaro, G Chiara, M Boiocchi, A Carbone, S Franceschi.   

Abstract

In a case-control study in northeastern Italy hepatitis C virus infection seemed to increase by about 50-fold the risk of non-Hodgkin's lymphoma involving the liver and major salivary glands (i.e. larger than that for hepatocellular carcinoma) and by about fourfold the risk of lymphomas at other sites.

Entities:  

Mesh：

Year:  1998        PMID： 9667688      PMCID： PMC2150369          DOI： 10.1038/bjc.1998.338

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  29 in total

1.  Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.

Authors:  V Guadagnino; T Stroffolini; M Rapicetta; A Costantino; L A Kondili; F Menniti-Ippolito; B Caroleo; C Costa; G Griffo; L Loiacono; V Pisani; A Focà; M Piazza
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

2.  High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders.

Authors:  L Cavanna; G Sbolli; E Tanzi; L Romanò; G Civardi; E Buscarini; D Vallisa; R Berté; A Rossi
Journal:  Haematologica       Date:  1995 Sep-Oct       Impact factor: 9.941

3.  HCV and non-Hodgkin lymphoma.

Authors:  P Pioltelli; G Zehender; G Monti; A Monteverde; M Galli
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

4.  Hepatitis C virus infection in patients with non-Hodgkin's lymphoma.

Authors:  C Ferri; F Caracciolo; A L Zignego; L La Civita; M Monti; G Longombardo; F Lombardini; F Greco; E Capochiani; A Mazzoni
Journal:  Br J Haematol       Date:  1994-10       Impact factor: 6.998

Review 5.  Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence.

Authors:  P Hartge; S S Devesa
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

6.  Mortality before and after HIV infection in the complete UK population of haemophiliacs. UK Haemophilia Centre Directors' Organisation.

Authors:  S C Darby; D W Ewart; P L Giangrande; P J Dolin; R J Spooner; C R Rizza
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

7.  Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia.

Authors:  S De Vita; D Sansonno; R Dolcetti; G Ferraccioli; A Carbone; V Cornacchiulo; G Santini; M Crovatto; A Gloghini; F Dammacco; M Boiocchi
Journal:  Blood       Date:  1995-09-01       Impact factor: 22.113

Review 8.  Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations.

Authors:  S C Gumber; S Chopra
Journal:  Ann Intern Med       Date:  1995-10-15       Impact factor: 25.391

9.  HCV-associated liver cancer without cirrhosis.

Authors:  M S De Mitri; K Poussin; P Baccarini; P Pontisso; A D'Errico; N Simon; W Grigioni; A Alberti; M Beaugrand; E Pisi
Journal:  Lancet       Date:  1995-02-18       Impact factor: 79.321

Review 10.  The aetiology of mixed cryoglobulinaemia associated with hepatitis C virus infection.

Authors:  V Agnello
Journal:  Scand J Immunol       Date:  1995-08       Impact factor: 3.487
View more
  11 in total

1.  Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site.

Authors:  Mohammad O Khalil; Lindsay M Morton; Susan S Devesa; David P Check; Rochelle E Curtis; Dennis D Weisenburger; Graça M Dores
Journal:  Br J Haematol       Date:  2014-01-12       Impact factor: 6.998

2.  Development of multiple myeloma in a patient with chronic hepatitis C: A case report and review of the literature.

Authors:  Peter Laszlo Lakatos; Sandor Fekete; Margit Horanyi; Simon Fischer; Margit E Abonyi
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

Review 3.  Hepatitis C virus infection induced vasculitis.

Authors:  Patrice Cacoub; David Saadoun
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 4.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

Review 5.  Morphologic features of extrahepatic manifestations of hepatitis C virus infection.

Authors:  Huaibin M Ko; Juan C Hernandez-Prera; Hongfa Zhu; Steven H Dikman; Harleen K Sidhu; Stephen C Ward; Swan N Thung
Journal:  Clin Dev Immunol       Date:  2012-08-05

Review 6.  Hepatitis c and lymphoma.

Authors:  F Silvestri; A Sperotto; R Fanin
Journal:  Curr Oncol Rep       Date:  2000-03       Impact factor: 5.945

7.  Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey.

Authors:  S Paydas; B Kiliç; B Sahin; R Buğdayci
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

Review 8.  Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in Korea.

Authors:  Hogil Kim; Yun Kyung Chung; Inah Kim
Journal:  Ann Occup Environ Med       Date:  2018-01-31

Review 9.  HCV and lymphoproliferation.

Authors:  Anna Linda Zignego; Carlo Giannini; Laura Gragnani
Journal:  Clin Dev Immunol       Date:  2012-07-19

10.  Virus-associated lymphomagenesis.

Authors:  V Z Tarantul
Journal:  Int J Biomed Sci       Date:  2006-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.